Forma Therapeutics (Nasdaq: FMTX) is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers.

Biotechnology

FORMA Therapeutics

FORMA Therapeutics' headquarters in Watertown, MA, United States

Katy Burnett

Mark Chamberlin

Irena Webster

Jim O'Connell

Jennifer Sweeney

Kirwyn Sutherland

Shihara Azard

Rebekah Leigh

Diego del Alcázar

Priscilla Ho

Lee Colbert

Donna Loonie

Paul Kelly

Peter Kolchinsky

Arturo Molina

Thomas G. Wiggans

Timothy P. Clackson

Wayne A. I. Frederick

Tim Clackson

The Research and Development team at FORMA Therapeutics is responsible for advancing innovative therapeutic candidates from preclinical to clinical stages, focusing on rare hematologic diseases and cancers. This multidisciplinary team collaborates on drug discovery, development strategies, and clinical trials, leveraging expertise in science, medical communications, informatics, and portfolio management to ensure successful outcomes and patient impact.

Research and Development

The Clinical Operations team at FORMA Therapeutics is responsible for overseeing the planning, execution, and management of clinical trials for their innovative therapeutics. They ensure compliance with regulatory standards, maintain high-quality data management, and collaborate with cross-functional teams to facilitate the successful development of treatments aimed at rare hematologic diseases and cancers.

Clinical Operations

The Finance and Legal team at FORMA Therapeutics is responsible for overseeing the company’s financial strategy, ensuring compliance with regulatory requirements, and managing legal matters. This team works to support the clinical development and commercialization of novel therapeutics by providing financial insights, legal guidance, and risk management to facilitate informed decision-making and protect the company's interests.

Finance and Legal

The Leadership Team at FORMA Therapeutics is responsible for guiding the strategic direction of the company, overseeing research and development initiatives, and ensuring compliance with legal and regulatory requirements. Comprised of executives from key areas such as Research & Development, Development Operations, and Legal, this team collaborates to drive innovation and advance the development of novel therapeutics for patients with rare hematologic diseases and cancers.

Leadership Team

FORMA Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Clinical Operations

Finance and Legal

Leadership Team

Offices

FORMA Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Clinical Operations

Finance and Legal

Leadership Team

Offices

Related companies